Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Regulation of lung progenitor plasticity and repair by fatty acid oxidation
Quetzalli D. Angeles-Lopez, Jhonny Rodriguez-Lopez, Paula Agudelo Garcia, Jazmin Calyeca, Diana Álvarez, Marta Bueno, Lan N. Tu, Myriam Salazar-Terreros, Natalia Vanegas-Avendaño, Jordan E. Krull, Aigul Moldobaeva, Srimathi Bogamuwa, Stephanie S. Scott, Victor Peters, Brenda F. Reader, Sruti Shiva, Michael Jurczak, Mahboobe Ghaedi, Qin Ma, Toren Finkel, Mauricio Rojas, Ana L. Mora
Quetzalli D. Angeles-Lopez, Jhonny Rodriguez-Lopez, Paula Agudelo Garcia, Jazmin Calyeca, Diana Álvarez, Marta Bueno, Lan N. Tu, Myriam Salazar-Terreros, Natalia Vanegas-Avendaño, Jordan E. Krull, Aigul Moldobaeva, Srimathi Bogamuwa, Stephanie S. Scott, Victor Peters, Brenda F. Reader, Sruti Shiva, Michael Jurczak, Mahboobe Ghaedi, Qin Ma, Toren Finkel, Mauricio Rojas, Ana L. Mora
View: Text | PDF
Research Article Metabolism Pulmonology

Regulation of lung progenitor plasticity and repair by fatty acid oxidation

  • Text
  • PDF
Abstract

Idiopathic pulmonary fibrosis (IPF) is an age-related interstitial lung disease, characterized by inadequate alveolar regeneration and ectopic bronchiolization. While some molecular pathways regulating lung progenitor cells have been described, the role of metabolic pathways in alveolar regeneration is poorly understood. We report that expression of fatty acid oxidation (FAO) genes is significantly diminished in alveolar epithelial cells of IPF lungs by single-cell RNA sequencing and tissue staining. Genetic and pharmacological inhibition in AT2 cells of carnitine palmitoyltransferase 1a (CPT1a), the rate-limiting enzyme of FAO, promoted mitochondrial dysfunction and acquisition of aberrant intermediate states expressing basaloid, and airway secretory cell markers SCGB1A1 and SCGB3A2. Furthermore, mice with deficiency of CPT1a in AT2 cells show enhanced susceptibility to developing lung fibrosis with an accumulation of epithelial cells expressing markers of intermediate cells, airway secretory cells, and senescence. We found that deficiency of CPT1a causes a decrease in SMAD7 protein levels and TGF-β signaling pathway activation. These findings suggest that the mitochondrial FAO metabolic pathway contributes to the regulation of lung progenitor cell repair responses and deficiency of FAO contributes to aberrant lung repair and the development of lung fibrosis.

Authors

Quetzalli D. Angeles-Lopez, Jhonny Rodriguez-Lopez, Paula Agudelo Garcia, Jazmin Calyeca, Diana Álvarez, Marta Bueno, Lan N. Tu, Myriam Salazar-Terreros, Natalia Vanegas-Avendaño, Jordan E. Krull, Aigul Moldobaeva, Srimathi Bogamuwa, Stephanie S. Scott, Victor Peters, Brenda F. Reader, Sruti Shiva, Michael Jurczak, Mahboobe Ghaedi, Qin Ma, Toren Finkel, Mauricio Rojas, Ana L. Mora

×

Figure 8

Cpt1a deficiency induces activation of the TGF-β pathway.

Options: View larger image (or click on image) Download as PowerPoint

Cpt1a deficiency induces activation of the TGF-β pathway.
Heatmap (A) a...
Heatmap (A) and scores (B), showing the gene expression and activation of the TGF-β pathway in each epithelial cell population from MHV-68–infected Cpt1a-floxed (n = 4) and Cpt1a Spc-KO (n = 6) mice. Violin plots display the distribution of data, statistical significance was determined by Wilcoxon’s test. (C) Dot plot depicting gene expression of the TGF-β pathway in the cell populations from iAT2 organoids. (D) Top: Scheme of the human alveolar organoid culture experimental design in the presence of TGF-β treatment. Bottom: Representative immunofluorescence images showing the increased presence of the secretory cell marker SCGB1A1 (red) in organoids treated with TGF-β on day 2 or 5 of differentiation (n = 4, each group). HOPX (green) was used as an AT1 marker and KRT17 (white) was used as a transitional cell marker. Scale bars: 50 μm. (E) Heatmap shows the increased expression of TGF-β target genes in Cpt1a-KD cells compared with scramble (n = 3, per condition). (F) Representative Western blot images depicting levels of total Smad 2/3, Smad7, and p-Smad 2/3 on the left, with quantification on the right (n = 2, each group). Data represent mean ± SD. (G) Representative Western blot images depicting levels of Smad7 in Cpt1a-KD cells after acetate treatment on the left, with quantification on the right (n = 2, each group). Data represent mean ± SD. Representative immunofluorescence (H) and quantification (I) showing a decrease in SCGB1A1 expression in human organoids treated with etomoxir and acetate. Data represent mean ± SD. Statistical significance was determined by 1-way ANOVA followed by Tukey’s multiple-comparison test. Scale bars: 50 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts